Syneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.
If you are not happy with the results below please do another search
50 search results for:
The White House coronavirus task force warned that much of the country is in the grips of an “unrelenting” surge in Covid-19 cases and urged tough countermeasures, as the reported number of U.S. infections hit a new daily record of more than 91,000.
Leading pharmaceutical companies – including Moderna, Pfizer and AstraZeneca – are racing ahead to develop and distribute a Covid-19 vaccine.
Global coronavirus cases rose by more than 500,000 for the first time, a record one-day increase as countries across the Northern Hemisphere reported daily spikes.
For the first time ever, Klick Health took its in-office flu shot clinic on the road in keeping with the company’s people-first culture and commitment to help keep team members and their families healthy and happy.
AstraZeneca and Daiichi Sankyo’s Enhertu received supplemental Biologics License Application (sBLA) acceptance and U.S. priority review for the treatment of HER2-positive metastatic gastric cancer.
Arcus Biosciences and AstraZeneca have partnered to evaluate a combination therapy as a potential treatment for advanced non-small cell lung cancer (NSCLC).
Sanofi is testing the company’s non-alpha IL-2 candidate THOR-707 with Merck’s checkpoint inhibitor Keytruda (pembrolizumab) in solid tumors.
Novartis acquired Cambridge, Massachusetts-based Vedere Bio in a deal totaling up to $280 million.
Fishawack Health launched a pro bono campaign on World Psoriasis Day to raise awareness that psoriasis is not a contagious or unhygienic condition and to help lessen the stigma, discrimination, and exclusion of the 125 million people living with the skin condition globally.